Ciaffoni Joseph's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Dec 20, 2023
- Accession no.
- 0001062993-23-022977
- Filed
- Dec 20, 2023
- Trade date
- Dec 18-20, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.08M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaffoni JosephCIK 0001443841 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Common Stock | MOption exerciseAcquired | +27,798 | $21.34 | +$593,209.32 | 302,798 | Direct | |
| Dec 18, 2023 | Common Stock | SSaleDisposed | −27,798 | $30.04 | −$835,051.92 | 275,000 | Direct | |
| Dec 19, 2023 | Common Stock | MOption exerciseAcquired | +14,516 | $21.34 | +$309,771.44 | 289,516 | Direct | |
| Dec 19, 2023 | Common Stock | SSaleDisposed | −14,516 | $30.03 | −$435,915.48 | 275,000 | Direct | |
| Dec 20, 2023 | Common Stock | MOption exerciseAcquired | +26,454 | $21.34 | +$564,528.36 | 301,454 | Direct | |
| Dec 20, 2023 | Common Stock | SSaleDisposed | −26,454 | $30.40 | −$804,201.6 | 275,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Common Stock | MOption exerciseDisposed | −27,798 | $0.00 | $0 | 62,202 | Direct | |
| Dec 19, 2023 | Common Stock | MOption exerciseDisposed | −14,516 | $0.00 | $0 | 47,686 | Direct | |
| Dec 20, 2023 | Common Stock | MOption exerciseDisposed | −26,454 | $0.00 | $0 | 21,232 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.